SI-BONE INC (SIBN) Stock Fundamental Analysis

NASDAQ:SIBN • US8257041090

15.65 USD
-0.05 (-0.32%)
Last: Mar 3, 2026, 09:35 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall SIBN gets a fundamental rating of 4 out of 10. We evaluated SIBN against 184 industry peers in the Health Care Equipment & Supplies industry. The financial health of SIBN is average, but there are quite some concerns on its profitability. SIBN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • SIBN had negative earnings in the past year.
  • SIBN had a negative operating cash flow in the past year.
  • In the past 5 years SIBN always reported negative net income.
  • SIBN had a negative operating cash flow in each of the past 5 years.
SIBN Yearly Net Income VS EBIT VS OCF VS FCFSIBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • SIBN's Return On Assets of -7.93% is fine compared to the rest of the industry. SIBN outperforms 63.59% of its industry peers.
  • SIBN has a better Return On Equity (-10.65%) than 67.39% of its industry peers.
Industry RankSector Rank
ROA -7.93%
ROE -10.65%
ROIC N/A
ROA(3y)-13.38%
ROA(5y)-21.75%
ROE(3y)-18.25%
ROE(5y)-31.84%
ROIC(3y)N/A
ROIC(5y)N/A
SIBN Yearly ROA, ROE, ROICSIBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400

1.3 Margins

  • SIBN's Gross Margin of 79.57% is amongst the best of the industry. SIBN outperforms 92.39% of its industry peers.
  • In the last couple of years the Gross Margin of SIBN has declined.
  • SIBN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.27%
GM growth 5Y-1.97%
SIBN Yearly Profit, Operating, Gross MarginsSIBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • SIBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SIBN has more shares outstanding than it did 1 year ago.
  • SIBN has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SIBN has been reduced compared to a year ago.
SIBN Yearly Shares OutstandingSIBN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
SIBN Yearly Total Debt VS Total AssetsSIBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • SIBN has an Altman-Z score of 5.67. This indicates that SIBN is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 5.67, SIBN is doing good in the industry, outperforming 79.89% of the companies in the same industry.
  • A Debt/Equity ratio of 0.20 indicates that SIBN is not too dependend on debt financing.
  • SIBN's Debt to Equity ratio of 0.20 is in line compared to the rest of the industry. SIBN outperforms 58.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 5.67
ROIC/WACCN/A
WACC9.88%
SIBN Yearly LT Debt VS Equity VS FCFSIBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 8.55 indicates that SIBN has no problem at all paying its short term obligations.
  • SIBN's Current ratio of 8.55 is amongst the best of the industry. SIBN outperforms 90.22% of its industry peers.
  • A Quick Ratio of 7.21 indicates that SIBN has no problem at all paying its short term obligations.
  • SIBN's Quick ratio of 7.21 is amongst the best of the industry. SIBN outperforms 90.22% of its industry peers.
Industry RankSector Rank
Current Ratio 8.55
Quick Ratio 7.21
SIBN Yearly Current Assets VS Current LiabilitesSIBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • SIBN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.11%, which is quite impressive.
  • Looking at the last year, SIBN shows a very strong growth in Revenue. The Revenue has grown by 20.19%.
  • The Revenue has been growing by 22.31% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)42.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.64%
Revenue 1Y (TTM)20.19%
Revenue growth 3Y23.6%
Revenue growth 5Y22.31%
Sales Q2Q%15%

3.2 Future

  • The Earnings Per Share is expected to grow by 22.35% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 14.82% on average over the next years. This is quite good.
EPS Next Y-17.95%
EPS Next 2Y5.6%
EPS Next 3Y11.8%
EPS Next 5Y22.35%
Revenue Next Year14.85%
Revenue Next 2Y14.9%
Revenue Next 3Y15.05%
Revenue Next 5Y14.82%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SIBN Yearly Revenue VS EstimatesSIBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
SIBN Yearly EPS VS EstimatesSIBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SIBN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SIBN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SIBN Price Earnings VS Forward Price EarningsSIBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SIBN Per share dataSIBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.6%
EPS Next 3Y11.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SIBN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SI-BONE INC

NASDAQ:SIBN (3/3/2026, 9:35:09 AM)

15.65

-0.05 (-0.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners99.59%
Inst Owner Change-3.3%
Ins Owners3.12%
Ins Owner Change7.84%
Market Cap691.26M
Revenue(TTM)200.93M
Net Income(TTM)-18.91M
Analysts83.75
Price Target25.91 (65.56%)
Short Float %6.33%
Short Ratio4.91
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)51.98%
Min EPS beat(2)35.08%
Max EPS beat(2)68.88%
EPS beat(4)4
Avg EPS beat(4)41.05%
Min EPS beat(4)25.4%
Max EPS beat(4)68.88%
EPS beat(8)8
Avg EPS beat(8)32.63%
EPS beat(12)12
Avg EPS beat(12)28.68%
EPS beat(16)14
Avg EPS beat(16)22.07%
Revenue beat(2)1
Avg Revenue beat(2)0.49%
Min Revenue beat(2)-1.23%
Max Revenue beat(2)2.22%
Revenue beat(4)2
Avg Revenue beat(4)0.68%
Min Revenue beat(4)-1.23%
Max Revenue beat(4)2.63%
Revenue beat(8)5
Avg Revenue beat(8)0.59%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)11
Avg Revenue beat(16)1.37%
PT rev (1m)-1.89%
PT rev (3m)2.05%
EPS NQ rev (1m)-0.35%
EPS NQ rev (3m)-1.88%
EPS NY rev (1m)0.21%
EPS NY rev (3m)11.61%
Revenue NQ rev (1m)1.57%
Revenue NQ rev (3m)2.64%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)1.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.44
P/FCF N/A
P/OCF N/A
P/B 3.89
P/tB 3.89
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS4.55
BVpS4.02
TBVpS4.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.93%
ROE -10.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.57%
FCFM N/A
ROA(3y)-13.38%
ROA(5y)-21.75%
ROE(3y)-18.25%
ROE(5y)-31.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.27%
GM growth 5Y-1.97%
F-Score6
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 145.82%
Cap/Sales 4.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.55
Quick Ratio 7.21
Altman-Z 5.67
F-Score6
WACC9.88%
ROIC/WACCN/A
Cap/Depr(3y)176.41%
Cap/Depr(5y)222.12%
Cap/Sales(3y)5.36%
Cap/Sales(5y)6.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.64%
EPS Next Y-17.95%
EPS Next 2Y5.6%
EPS Next 3Y11.8%
EPS Next 5Y22.35%
Revenue 1Y (TTM)20.19%
Revenue growth 3Y23.6%
Revenue growth 5Y22.31%
Sales Q2Q%15%
Revenue Next Year14.85%
Revenue Next 2Y14.9%
Revenue Next 3Y15.05%
Revenue Next 5Y14.82%
EBIT growth 1Y36.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year141.33%
EBIT Next 3Y51.06%
EBIT Next 5Y37.45%
FCF growth 1Y60.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.57%
OCF growth 3YN/A
OCF growth 5YN/A

SI-BONE INC / SIBN FAQ

What is the fundamental rating for SIBN stock?

ChartMill assigns a fundamental rating of 4 / 10 to SIBN.


Can you provide the valuation status for SI-BONE INC?

ChartMill assigns a valuation rating of 0 / 10 to SI-BONE INC (SIBN). This can be considered as Overvalued.


How profitable is SI-BONE INC (SIBN) stock?

SI-BONE INC (SIBN) has a profitability rating of 2 / 10.


What is the earnings growth outlook for SI-BONE INC?

The Earnings per Share (EPS) of SI-BONE INC (SIBN) is expected to decline by -17.95% in the next year.